DS 11960558

Drug Profile

DS 11960558

Alternative Names: DS11960558; Prodrug of DS 2969b

Latest Information Update: 27 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Daiichi Sankyo Company
  • Class Antibacterials; Antidiarrhoeals
  • Mechanism of Action DNA gyrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Clostridium infections

Most Recent Events

  • 04 Oct 2017 Preclinical trials in Clostridium infections in Japan (IV)
  • 04 Oct 2017 Pharmacodynamics, safety and pharmacokinetics data from a preclinical study in Clostridium infections presented at the IDWeek 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top